Of interest are myocytes, as skeletal myopathy is the most notable feature of clinical cases of YARS2 variants (15, 17), and additionally peripheral neurons, which are affected in most clinical cases of ARS2 variants (35, 36). This evidence concerns the gene YARS2 and skeletal muscle disorder.